首页|甲状腺乳头状癌患者TCAB1、lncRNA DLEU2表达与临床病理参数及预后的相关性

甲状腺乳头状癌患者TCAB1、lncRNA DLEU2表达与临床病理参数及预后的相关性

扫码查看
目的 探讨甲状腺乳头状癌(PTC)患者组织中端粒酶卡哈尔体蛋白1(TCAB1)、长链非编码RNA DLEU2(lncRNA DLEU2)表达与临床病理参数及预后的相关性。方法 前瞻性选取陕西省肿瘤医院2018年1月至2021年1月收治的80例PTC患者。其中,男35例,女45例;年龄38~78(54。65±4。75)岁。取所有受检者术后癌组织及癌旁正常组织进行免疫组化检验。采用免疫组织化学染色方法检测癌组织及癌旁正常组织TCAB1、lncRNA DLEU2的表达水平,分析不同病理参数患者TCAB1、lncRNA DLEU2表达情况,采用Spearman相关性分析TCAB1、lncRNA DLEU2与PTC临床病理参数的相关性。对所有患者进行3年随访,将发生新的转移灶、复发灶及死亡的患者分为预后不良组(20例),其余患者为预后良好组(60例)。分析两组患者TCAB1、lncRNA DLEU2表达水平,采用logisiic回归分析模型分析TCAB1、lncRNA DLEU2对PTC的预后预测价值。行t检验、x2检验。结果 癌组织lncRNA DLEU2相对表达量与TCAB1阳性率均高于癌旁组织[(1。44±0。27)比(0。75±0。12),72。78%(49/80)比 14。79%(22/80)],差异均有统计学意义(t=16。14,x2=18。46,均P<0。05);不同 TNM 分期、淋巴结转移情况患者lncRNA DLEU2相对表达量、TCAB1阳性率对比差异均有统计学意义(均P<0。05);Spearman相关分析结果显示TCAB1与临床分期、淋巴结转移呈正相关(r=0。428,0。353;均P<0。05),lncRNA DLEU2与临床分期、淋巴结转移呈正相关(r=0。430,0。401;均P<0。05);预后不良组lncRNA DLEU2相对表达量与TCAB1阳性率均高于预后良好组[(1。68±0。25)比(1。25±0。13),85。00%(17/20)比 53。33%(32/60)],差异均有统计学意义(t=8。48,x2=6。34,均 P<0。05);TCAB1 阳性表达、lncRNA DLEU2相对表达量增加为PTC预后独立影响因素(OR=2。791,95%CI 1。457~5。745;OR=2。146,95%CI 1。525~6。795),均P<0。001)。结论 PTC患者TCAB1、lncRNA DLEU2表达水平与PTC的发生与发展密切相关,可通过检测TCAB1、lncRNA DLEU2表达来预测患者预后情况。
Correlation of expression levels of TCAB1 and lncRNA DLEU2 with and clinical pathological parameters and prognosis in patients with papillary thyroid carcinoma
Objective To investigate the correlation of the expression levels of telomerase Cahalin protein 1(TCAB1)and long chain non-coding RNA(lncRNA)DLEU2 in the tissues of patients with papillary thyroid carcinoma with their clinical pathological parameters and prognosis.Methods Eighty patients with PTC treated at Shaanxi Provincial Tumor Hospital from January 2018 to January 2021 were selected,including 35 males and 45 females who were 38-78(54.65±4.75)years old.The patients'cancer tissue and adjacent tissue were collected for immunohistochemical examination.The immunohistochemical staining was used to detect the expression levels of TCAB1 and lncRNA DLEU2 in the cancer tissue and adjacent tissue.The expression levels of TCAB1 and lncRNA DLEU2 in the patients with different pathological parameters were analyzed.Spearman correlation analysis was used to analyze the correlation of TCAB1 and lncRNA DLEU2 with the clinical pathological parameters of PTC.All the patients were followed up for 3 years,and were divided into 2 subgroups based on their prognosis.Twenty patients with new metastases and recurrent lesions and who died were set as a poor prognosis group.The remaining 60 patients were set as a good prognosis group.The expression levels of TCAB1 and lncRNA DLEU2 in the two groups were analyzed.The logistic regression analysis model was used to analyze the prognostic predictive values of TCAB1 and lncRNA DLEU2 for PTC.t andx2 tests were used.Results The relative expression level of lncRNA DLEU2 and the positive rate of TCAB1 in the cancer tissue were significantly higher than those in the adjacent tissue[(1.44±0.27)vs.(0.75±0.12),72.78%(49/80)vs.14.79%(22/80),],with statistical differences(t=16.14;x2=18.46;both P<0.05).There were statistical differences in the relative expression of lncRNA DLEU2 and TCAB1 positivity rate between the patients with different TNM stages and with and without lymph node metastases(all P<0.05).The results of Spearman correlation analysis showed that TCAB1 was positively associated with clinical stage and lymph node metastasis(r=0.428 and 0.353;both P<0.05),and lncRNA DLEU2 was positively associated with clinical stage and lymph node metastasis(r=0.430 and 0.401;both P<0.05).The relative expression level of lncRNA DLEU2 and the positive rate of TCAB1 in the poor prognosis group were significantly higher than those in the good prognosis group[(1.68±0.25)vs.(1.25±0.13)and 85.00%(17/20)vs.53.33%(32/60)],with statistical differences(t=8.48 andx2=6.34;both P<0.05).Positive expression of TCAB1 and increased relative expression of lncRNA DLEU2 were independent prognostic factors for PTC(OR=2.791,95%CI 1.457-5.745;OR=2.146,95%CI 1.525-6.795;both P<0.001).Conclusions The expression levels of TCAB1 and lncRNA DLEU2 in the cancer tissue of PTC patients are increased,and are closely related to the occurrence and development of PTC.The expression levels of TCAB1 and lncRNA DLEU2 can be detected to predict the prognosis of patients with PTC.

Thyroid cancerThyroid papillary carcinomaTelomerase Cahalin protein 1Long chain non-coding RNAPathological parametersPrognosis

戚新春、李阳、程卫

展开 >

陕西省肿瘤医院头颈肿瘤科,西安 710000

甲状腺癌 甲状腺乳头状癌 端粒酶卡哈尔体蛋白1 长链非编码RNA 病理参数 预后

陕西重点研发计划

2021SF-011

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(19)